文献速递神经眼科

急性视神经炎的临床预测因素:基于临床试验数据的分析

Clinical Predictors in Acute Optic Neuritis: Analysis Based on Clinical Trial Data.
PubMed 文献 · Ophthalmology · 2025-01-17

本研究基于TONE试验队列103例首次急性单侧视神经炎患者,分析6个月视觉结局的基线临床预测因素。多因素回归显示,基线高对比度视力较高与多数结局较好相关,男性与多数结局较差相关,年龄较大与功能结局较差相关。作者认为年龄较大、男性及初始视觉功能较差者临床结局可能更差。

要点

  • 基线高对比度视力较高与除VEP传导时间外所有指标结局较好相关。
  • 男性与除高对比度视力外所有指标结局较差相关。
  • 年龄较大与功能结局较差相关。

核心结论

  • 年龄较大、男性及初始视觉功能较差的患者在急性视神经炎中可能面临更差的临床结局。

研究设计与样本

  • TONE研究(NCT01962571)队列数据的二次分析,纳入103例首次急性单侧视神经炎患者,基线高对比度视力≤20/40 Snellen(logMAR 0.3),2014年11月25日至2017年10月9日从12家德国大学医院招募。
  • 因TONE试验药物促红细胞生成素对视觉系统无影响,所有分析使用合并(不区分治疗)数据。

主要发现

  • 多因素回归中,基线高对比度视力较高与除VEP传导时间外所有指标结局较好相关。
  • 男性与除高对比度视力外所有指标结局较差相关。
  • 年龄较大与功能结局较差相关。

关键数值与推荐

  • 基线高对比度视力≤20/40 Snellen(logMAR 0.3)为纳入标准。
  • 结局指标包括6个月时高对比度视力、低对比度字母视力、视觉诱发电位P100峰时、黄斑神经节细胞及内丛状层厚度、视盘周围视网膜神经纤维层厚度。

临床怎么用

  • 作者认为该知识可能有助于个体化患者咨询、促进为时间敏感且侵入性免疫调节治疗选择患者,并可用于确保临床神经保护试验中风险特征平衡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify baseline clinical predictors of visual outcomes 6 months after acute optic neuritis using data from our completed clinical neuroprotection trial: Treatment of Optic Neuritis with Erythropoietin (TONE). DESIGN: Secondary analysis of data from the TONE study cohort (NCT01962571). PARTICIPANTS: A total of 103 patients presenting within 10 days of a first episode of acute unilateral optic neuritis as a clinically isolated syndrome with baseline high-contrast visual acuity (HCVA) ≤20/40 Snellen (logarithm of the minimum angle of resolution 0.3). Patients were recruited from 12 German university hospitals between November 25, 2014, and October 9, 2017. METHODS: We selected potential predictors based on literature research and experience, and then computed initial linear regression models that each included 1 predictor together with the baseline value of the outcome of interest. We used a forward-selection approach to build a multiple regression model for each outcome. Because the trial medication of the TONE study (erythropoietin) had no effect on the visual system, we used pooled (treatment-agnostic) data for all analyses. MAIN OUTCOME MEASURES: Independent predictors of HCVA, low-contrast letter acuity, visual-evoked potential (VEP) P100 peak times, macular ganglion cell and inner plexiform layer thickness, and peripapillary retinal nerve fiber layer thickness at 6 months. RESULTS: On multiple regression, the most consistent predictors were higher baseline HCVA, which was associated with better outcomes across all measures except VEP conduction time; male sex, which predicted worse outcomes for all measures except HCVA; and older age, which was linked to poorer functional outcomes. CONCLUSIONS: Patients who are older, are male, and present with worse initial visual function may be at risk for worse clinical outcomes in acute optic neuritis. This knowledge may inform individual patient counseling, facilitate patient selection for time-sensitive and invasive immunomodulatory treatments, and can be used to ensure balanced risk characteristics in clinical neuroprotection trials. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Küchlin S, Ihorst G, Heinrich SP, et al. Clinical Predictors in Acute Optic Neuritis: Analysis Based on Clinical Trial Data. Ophthalmology. 2025. PMID: 39827907. doi:10.1016/j.ophtha.2025.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。